Civil Law

Healthcare & Life Sciences Private Equity Deal Tracker: J.P. Morgan Life Sciences Invests in Turbett Surgical

J.P. Morgan Life Sciences Private Capital has invested in Turbett Surgical, according to a news release.

Turbett, founded in 2013 and based in Henrietta, New York, is a medical equipment company that manufactures mobile sterilization pods and consumable filters for surgical equipment sterilization.

J.P. Morgan Life Sciences Private Capital is the life sciences platform of J.P. Morgan Private Capital. The platform invests in early-stage biotherapeutics and late-stage healthcare companies.

Terms of the investment were not disclosed.

LexBlog… Read the rest

Civil Law

Healthcare & Life Sciences Private Equity Deal Tracker: Vance Street Acquires Injectech

Vance Street Capital has announced its acquisition of Injectech from The West Group (TWG).

Injectech, founded in 1998 and based in Fort Collins, Colorado, is a manufacturer of luer locks, bond-in luers, check valves, tube to tube connectors and spikes for the medical industry.

Vance Street, founded in 2007 and based in Los Angeles, is a middle market private equity firm that invests in several sectors, including medical technology and life science. The firm typically pursues companies with between $ … Read the rest

Civil Law

FCA PS25/17: The SI regime for bonds and derivatives including Discussion Paper on equity markets

On 28 November 2025, the Financial Conduct Authority (FCA) published Policy Statement 25/17: The SI regime for bonds and derivatives including Discussion Paper on equity markets (PS25/17).

Background

In November 2024, the FCA published Policy Statement 24/14 which introduced new bond and derivative transparency rules for trading venues from 1 December 2025. The regulator also included in chapter 9 of the Policy Statement a short section for discussion on the future of the systematic internaliser (… Read the rest